Intelligent Fingerprinting Drug Testing Solution
Commercial- Indications
- Drug screening
Company intelligence / Profile preview
The company’s flagship product—the Intelligent Fingerprinting Drug Screening System—has demonstrated high accuracy (94.1%) and specificity (100%) in clinical studies. It provides rapid (<10 min), non-invasive workplace drug testing via fingerprint sweat analysis. The system has over a thousand readers installed globally with more than 450 active customer accounts across multiple industries. U.S. launch pending FDA clearance expected in H1 of calendar year 2025.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intelligent Bio Solutions.